ID23192A - PROLIPOSOMA POWDER FOR INHABILITATION IN STABILIZED BY TOKOFEROL - Google Patents

PROLIPOSOMA POWDER FOR INHABILITATION IN STABILIZED BY TOKOFEROL

Info

Publication number
ID23192A
ID23192A IDW991656A ID991656A ID23192A ID 23192 A ID23192 A ID 23192A ID W991656 A IDW991656 A ID W991656A ID 991656 A ID991656 A ID 991656A ID 23192 A ID23192 A ID 23192A
Authority
ID
Indonesia
Prior art keywords
proliposoma
inhabilitation
tokoferol
stabilized
powder
Prior art date
Application number
IDW991656A
Other languages
Indonesian (id)
Inventor
Katarina Bystrom
Per-Gunnar Nilson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of ID23192A publication Critical patent/ID23192A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IDW991656A 1997-06-27 1998-06-08 PROLIPOSOMA POWDER FOR INHABILITATION IN STABILIZED BY TOKOFEROL ID23192A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27

Publications (1)

Publication Number Publication Date
ID23192A true ID23192A (en) 2000-03-23

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991656A ID23192A (en) 1997-06-27 1998-06-08 PROLIPOSOMA POWDER FOR INHABILITATION IN STABILIZED BY TOKOFEROL

Country Status (18)

Country Link
EP (1) EP1001749A1 (en)
JP (1) JP2002510311A (en)
KR (1) KR20010014163A (en)
CN (1) CN1260713A (en)
AU (1) AU729100B2 (en)
BR (1) BR9810280A (en)
CA (1) CA2295028A1 (en)
EE (1) EE9900601A (en)
HU (1) HUP0003207A3 (en)
ID (1) ID23192A (en)
IL (1) IL133478A0 (en)
IS (1) IS5304A (en)
NO (1) NO996439L (en)
NZ (1) NZ501672A (en)
PL (1) PL337723A1 (en)
SK (1) SK184899A3 (en)
TR (1) TR199903271T2 (en)
WO (1) WO1999000111A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138310A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138313A1 (en) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
JP5846711B2 (en) * 2005-06-09 2016-01-20 メダ アーベー Methods and compositions for the treatment of inflammatory diseases
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
EP2993995B1 (en) * 2013-05-06 2018-04-11 DSM IP Assets B.V. Powderous vitamin e formulation
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CN105078963B (en) * 2015-09-29 2018-06-22 中山大学 Alpha-tocopherol is preparing the application in treating snail fever drug
JP2020503269A (en) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド Oral testosterone undecanoate therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA95160463B1 (en) * 1994-12-22 2005-10-04 استرا أكتيبولاج powders for inhalation

Also Published As

Publication number Publication date
HUP0003207A2 (en) 2001-02-28
AU7945698A (en) 1999-01-19
PL337723A1 (en) 2000-08-28
EE9900601A (en) 2000-08-15
HUP0003207A3 (en) 2001-03-28
TR199903271T2 (en) 2000-08-21
JP2002510311A (en) 2002-04-02
CN1260713A (en) 2000-07-19
SK184899A3 (en) 2000-05-16
WO1999000111A1 (en) 1999-01-07
BR9810280A (en) 2000-09-12
EP1001749A1 (en) 2000-05-24
CA2295028A1 (en) 1999-01-07
NO996439L (en) 2000-02-28
NZ501672A (en) 2001-06-29
IS5304A (en) 1999-12-15
NO996439D0 (en) 1999-12-23
IL133478A0 (en) 2001-04-30
AU729100B2 (en) 2001-01-25
KR20010014163A (en) 2001-02-26

Similar Documents

Publication Publication Date Title
ID26509A (en) COMPONENTS THAT CONTAIN TETRAHIDROLIPSTATIN
ID26330A (en) VITAMIN K MODIFICATED POLIPEPTIDES
ID23980A (en) STRUCTURAL ABRACY MATERIALS THAT ARE FIXED BY FUNCTIONAL POWDER
ID28110A (en) ALFYLBENZENASULFONATE SURFACTED ENHANCED
ID24472A (en) MAKING POWDER AGLOMERATE
ID27741A (en) STABILIZED SOLIDED SOLIDIDE
ID28055A (en) CONTAINERS CONTAINED
EE04707B1 (en) Powder inhaler
ID22839A (en) WELL BEAUTIFUL WELL
ID26317A (en) EXTENDED FORMULATION
ID23192A (en) PROLIPOSOMA POWDER FOR INHABILITATION IN STABILIZED BY TOKOFEROL
IS5536A (en) Preparation for cosmetics
DE69904255D1 (en) metering
ID21770A (en) PLESTER THAT CONTAINS FELBINAK
ID19658A (en) PLACE FOR POWDER INK
DE59909560D1 (en) Powder feed injector
DE59909297D1 (en) Carbonyleisensilizid powder
ID16154A (en) STABILIZED MONOMER COMPOSITION
GB9726008D0 (en) Eletrolyte
DE69806324D1 (en) feed metering
ID26723A (en) COMPOSITION THAT CONTAINS MINOXIDIL FOR USE OUTSIDE
NO972389D0 (en) Cylinder-rotating mooring powder
DE69823490D1 (en) antiperspirant PREPARATION
ID23429A (en) SOLID SERTRALINA COMPOSITIONS
DE69937138D1 (en) COMPOSITE POWDER